Skip to main content
Intensive Care Medicine Experimental
Fig. 2 | Intensive Care Medicine Experimental

Fig. 2

From: Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats

Fig. 2

Haemodynamic parameters after sepsis induction, until 3 h after the injection of Adrecizumab or placebo. Haemodynamic parameters measured 24 h after sepsis induction by CLP and then 60, 120, and 180 min after the injection of Adrecizumab or placebo. CLP rats are represented by the black line, CLP-Adrecizumab rats by the red line, and CLP-NE rats by the grey line. Two-way ANOVA was used. *p < 0.05

Back to article page